Outcomes of hematopoietic cell transplantation using donors or recipients with inherited chromosomally integrated HHV-6.

Human herpesvirus 6 (HHV-6) species have a unique ability to integrate into chromosomal telomeres. Mendelian inheritance via gametocyte integration results in HHV-6 in every nucleated cell. The epidemiology and clinical effect of inherited chromosomally integrated HHV-6 (iciHHV-6) in hematopoietic cell transplant (HCT) recipients is unclear. We identified 4319 HCT donor-recipient pairs (8638 subjects) who received an allogeneic HCT and had archived pre-HCT peripheral blood mononuclear cell samples. We screened these samples for iciHHV-6 and compared characteristics of HCT recipients and donors with iciHHV-6 with those of recipients and donors without iciHHV-6, respectively. We calculated Kaplan-Meier probability estimates and Cox proportional hazards models for post-HCT outcomes based on recipient and donor iciHHV-6 status. We identified 60 HCT recipients (1.4%) and 40 donors (0.9%) with iciHHV-6; both recipient and donor harbored iciHHV-6 in 13 HCTs. Thus, there were 87 HCTs (2%) in which the recipient, donor, or both harbored iciHHV-6. Acute graft-versus-host disease (GVHD) grades 2-4 was more frequent when recipients or donors had iciHHV-6 (adjusted hazard ratios, 1.7-1.9; P = .004-.001). Cytomegalovirus viremia (any and high-level) was more frequent among recipients with iciHHV-6 (adjusted HRs, 1.7-3.1; P = .001-.040). Inherited ciHHV-6 status did not significantly affect risk for chronic GVHD, hematopoietic cell engraftment, overall mortality, or nonrelapse mortality. Screening for iciHHV-6 could guide donor selection and post-HCT risk stratification and treatment. Further study is needed to replicate these findings and identify potential mechanisms.

[1]  L. Beura,et al.  Implications of Resident Memory T Cells for Transplantation , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[2]  J. Schiffer,et al.  The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality. , 2017, Blood.

[3]  A. Becker,et al.  Human Herpesvirus 6B Induces Hypomethylation on Chromosome 17p13.3, Correlating with Increased Gene Expression and Virus Integration , 2017, Journal of Virology.

[4]  Human Herpesvirus , 2016, Red Book Atlas of Pediatric Infectious Diseases, 3rd Ed.

[5]  M. Boeckh,et al.  Efficient identification of inherited chromosomally integrated human herpesvirus 6 using specimen pooling. , 2016, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[6]  M. Sharland.  Human herpesvirus 6 and 7 , 2016 .

[7]  W. Wood,et al.  Late Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[8]  M. Sorror,et al.  CMV Viral Load and Mortality after Hematopoietic Cell Transplantation: A Cohort Study in the Era of Preemptive Therapy , 2016, The Lancet. Haematology.

[9]  M. Boeckh,et al.  Detection of Human Herpesvirus 6B (HHV-6B) Reactivation in Hematopoietic Cell Transplant Recipients with Inherited Chromosomally Integrated HHV-6A by Droplet Digital PCR , 2016, Journal of Clinical Microbiology.

[10]  G. Jahn,et al.  Individuals with inherited chromosomally integrated human herpes virus 6 (ciHHV-6) have functionally active HHV-6 specific T-cell immunity. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[11]  Effie W Petersdorf,et al.  High HLA-DP Expression and Graft-versus-Host Disease. , 2015, The New England journal of medicine.

[12]  G. Morissette,et al.  Inherited chromosomally integrated human herpesvirus 6 as a predisposing risk factor for the development of angina pectoris , 2015, Proceedings of the National Academy of Sciences.

[13]  M. Boeckh,et al.  Prevalence of chromosomally integrated human herpesvirus 6 in patients with human herpesvirus 6-central nervous system dysfunction. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[14]  J. Hill,et al.  Roseoloviruses in transplant recipients: clinical consequences and prospects for treatment and prevention trials. , 2014, Current opinion in virology.

[15]  E. Nacheva,et al.  Detection of HHV-6-specific mRNA and antigens in PBMCs of individuals with chromosomally integrated HHV-6 (ciHHV-6). , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[16]  T. Morio,et al.  Molecular and virological evidence of viral activation from chromosomally integrated human herpesvirus 6A in a patient with X-linked severe combined immunodeficiency. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  M. Boeckh,et al.  Identification of chromosomally integrated human herpesvirus 6 by droplet digital PCR. , 2014, Clinical chemistry.

[18]  A. Jeffreys,et al.  Human telomeres that carry an integrated copy of human herpesvirus 6 are often short and unstable, facilitating release of the viral genome from the chromosome , 2013, Nucleic acids research.

[19]  W. Leisenring,et al.  HHV-6 reactivation and associated sequelae after hematopoietic cell transplantation. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[20]  H. Agut,et al.  Chromosomally integrated human herpesvirus 6: questions and answers , 2011, Reviews in medical virology.

[21]  Sang-Oh Lee,et al.  Clinical Significance of Pretransplant Chromosomally Integrated Human Herpesvirus-6 in Liver Transplant Recipients , 2011, Transplantation.

[22]  Jesse H. Arbuckle,et al.  The latent human herpesvirus-6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro , 2010, Proceedings of the National Academy of Sciences.

[23]  M. Maris,et al.  Effect of conditioning regimen intensity on CMV infection in allogeneic hematopoietic cell transplantation. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[24]  P. Lansdorp,et al.  Telomerase mutations in families with idiopathic pulmonary fibrosis. , 2007, The New England journal of medicine.

[25]  W. Leisenring,et al.  An acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimens. , 2006, Blood.

[26]  J. Kamil,et al.  Marek's disease virus: from miasma to model , 2006, Nature Reviews Microbiology.

[27]  P. Griffiths,et al.  Transmission of integrated human herpesvirus 6 through stem cell transplantation: implications for laboratory diagnosis. , 2006, The Journal of infectious diseases.

[28]  S. Chanock,et al.  Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. , 2005, The New England journal of medicine.

[29]  A. Wald,et al.  A population-based study of primary human herpesvirus 6 infection. , 2005, The New England journal of medicine.

[30]  H. Kurahashi,et al.  Human herpesvirus 6 (HHV‐6) is transmitted from parent to child in an integrated form and characterization of cases with chromosomally integrated HHV‐6 DNA , 2004, Journal of medical virology.

[31]  H. Deeg,et al.  Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation. , 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[32]  L. Corey,et al.  Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  Margaret A. Strong,et al.  The Shortest Telomere, Not Average Telomere Length, Is Critical for Cell Viability and Chromosome Stability , 2001, Cell.

[34]  H. Taguchi,et al.  Integration of human herpesvirus 6 in a Burkitt's lymphoma cell line , 1998, British journal of haematology.

[35]  J. Hill,et al.  Human herpesvirus 6 and the nervous system. , 2014, Handbook of clinical neurology.

[36]  U. Gompels.  Human herpesvirus 6 and 7 , 2010 .

[37]  Thomas F. Smith,et al.  Selective reactivation of human herpesvirus 6 variant a occurs in critically ill immunocompetent hosts. , 2002, The Journal of infectious diseases.